Fusion Biologics

Fusion Biologics is a private, commercial-stage company leveraging human amniotic membrane to create biologic wound care products. Its core business involves processing and supplying sterile amniotic skin grafts directly to healthcare providers for the treatment of chronic wounds, burns, and surgical recovery. The company emphasizes product customization, regulatory compliance, and provider training as key differentiators. Operating from San Diego, it appears to be an early-revenue entity focused on penetrating the regenerative wound care market.

Proprietary processing and preservation of human amniotic membrane to create bioactive allografts for wound healing and tissue regeneration.

Fusion Biologics competes in a crowded market with established players like Organogenesis (Apligraf, Dermagraft), MiMedx (Epifix), and Smith & Nephew, as well as numerous other private tissue processing companies. Differentiation is achieved through product quality, customization, customer service, and provider training.